IO Biotech, Inc.
IOBT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $24 | $92 | $72 | $61 |
| - Cash | $31 | $28 | $37 | $60 |
| + Debt | $1 | $8 | $2 | $2 |
| Enterprise Value | -$5 | $72 | $36 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$9 | -$26 | -$22 | -$31 |
| % Margin | – | – | – | – |
| Net Income | -$8 | -$26 | -$22 | -$31 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.13 | -0.4 | -0.34 | -0.48 |
| % Growth | 67.5% | -17.6% | 29.2% | – |
| Operating Cash Flow | -$18 | -$20 | -$23 | -$20 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$18 | -$20 | -$23 | -$20 |